128 related articles for article (PubMed ID: 29394716)
1. [Four Cases of Gastrointestinal Perforation Associated with Bevacizumab].
Uemura K; Takahashi H; Mino K; Ota T; Shichi S
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1604-1606. PubMed ID: 29394716
[TBL] [Abstract][Full Text] [Related]
2. [Two Episodes of Colostomy-Associated Intestinal Perforation during Chemotherapy for Metastatic Rectal Cancer].
Tamura H; Otani A; Tsukui M; Toge K; Otani T; Hirose Y; Morimoto Y; Yoshino K; Kido T; Endo K; Kameyama H; Kobayashi T; Wakai T
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2172-2174. PubMed ID: 28133259
[TBL] [Abstract][Full Text] [Related]
3. [Four cases of bevacizumab-related gastrointestinal perforation].
Uchino T; Mishima H; Kimura K; Mori D; Ando K; Nagata H; Kondo R; Kosaka K; Ohashi N; Ito N; Arikawa T; Miyachi M; Suzumura K; Sano T; Nonami T
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2506-8. PubMed ID: 25731572
[TBL] [Abstract][Full Text] [Related]
4. [Two Cases of Bowel Perforation during Chemotherapy with Bevacizumab to Metastatic Rectal Cancer].
Miyake Y; Ikeda K; Murakami M; Oka Y; Nezu R; Kurokawa E; Kikkawa N
Gan To Kagaku Ryoho; 2015 Dec; 42 Suppl 1():75-8. PubMed ID: 26809419
[TBL] [Abstract][Full Text] [Related]
5. [A Case of Fournier's Gangrene Caused by Small Intestinal Perforation during Bevacizumab Combination Chemotherapy].
Ishida T; Shinozaki H; Ozawa H; Kobayashi T; Kato S; Wakabayashi T; Matsumoto K; Sasakura Y; Shimizu T; Terauchi T; Kimata M; Furukawa J; Kobayashi K; Ogata Y
Gan To Kagaku Ryoho; 2016 Jul; 43(7):909-11. PubMed ID: 27431640
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy and safety of bevacizumab (BEV) plus chemotherapeutic agents in the treatment of metastatic colorectal cancer, mCRC].
Guo X; Liu TS; Yu YY; Zhou YH; Chen Y; Zhuang RY; Cui YH
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):604-7. PubMed ID: 24314219
[TBL] [Abstract][Full Text] [Related]
7. [Conversion Therapy of Initially Unresectable Rectal Cancer with Perforation via FOLFOX4 Chemotherapy].
Yamada C; Ishikawa F; Nitta H; Fujita Y; Omoto H; Kamata S; Ito H
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2328-9. PubMed ID: 26805353
[TBL] [Abstract][Full Text] [Related]
8. [A Patient with Rectal Cancer and Multiple Lung Metastases Treated with XELOX plus Bevacizumab (Bev) Therapy].
Noura S; Ohue M; Miyoshi N; Yasui M; Sugimoto N; Okami J; Higashiyama M; Fujiwara Y; Yano M; Sakon M
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2097-9. PubMed ID: 26805276
[TBL] [Abstract][Full Text] [Related]
9. [Two Cases of Metastatic Rectal Cancer Patients Who Received Chemotherapy with FOLFOXIRI plus Bevacizumab].
Nishii T; Uchima Y; Yamakoshi Y; Wang E; Nagashima D; Hirakawa T; Aomatsu N; Iwauchi T; Morimoto J; Nakazawa K; Tei S; Takeuchi K
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1705-1707. PubMed ID: 28133105
[TBL] [Abstract][Full Text] [Related]
10. [A case of metachronous gastrointestinal perforation of a patient with metastatic rectal cancer during treatment with bevacizumab-based chemotherapy].
Sadatomo A; Koinuma K; Miki A; Horie H; Yasuda Y
Gan To Kagaku Ryoho; 2013 Jul; 40(7):943-5. PubMed ID: 23863742
[TBL] [Abstract][Full Text] [Related]
11. PRONOUNCE: randomized, open-label, phase III study of first-line pemetrexed + carboplatin followed by maintenance pemetrexed versus paclitaxel + carboplatin + bevacizumab followed by maintenance bevacizumab in patients ith advanced nonsquamous non-small-cell lung cancer.
Zinner RG; Obasaju CK; Spigel DR; Weaver RW; Beck JT; Waterhouse DM; Modiano MR; Hrinczenko B; Nikolinakos PG; Liu J; Koustenis AG; Winfree KB; Melemed SA; Guba SC; Ortuzar WI; Desaiah D; Treat JA; Govindan R; Ross HJ
J Thorac Oncol; 2015 Jan; 10(1):134-42. PubMed ID: 25371077
[TBL] [Abstract][Full Text] [Related]
12. [A case of lung cancer in an elderly patient with malignant pleural effusion and pneumothorax treated with carboplatin, pemetrexed, and bevacizumab].
Miyahara E; Itagaki T; Kuwahara M; Kameda A; Oue N
Gan To Kagaku Ryoho; 2014 Oct; 41(10):1237-40. PubMed ID: 25335706
[TBL] [Abstract][Full Text] [Related]
13. Bevacizumab-induced intestinal perforation in a patient with inoperable breast cancer: a case report and review of the literature.
Fujii Y; Hirahara N; Kaji S; Taniura T; Hyakudomi R; Yamamoto T; Tajima Y
J Med Case Rep; 2018 Mar; 12(1):84. PubMed ID: 29580267
[TBL] [Abstract][Full Text] [Related]
14. [A Case of Fournier's Gangrene Due to Perforation of Lower Rectal Cancer during Chemotherapy].
Fukuhisa H; Baba K; Kita Y; Tanabe H; Ijichi T; Mori S; Natsugoe S
Gan To Kagaku Ryoho; 2017 Oct; 44(10):935-937. PubMed ID: 29066701
[TBL] [Abstract][Full Text] [Related]
15. [A Case of Gastrointestinal Perforation in a Patient with Colon Cancer and Stent Placement during Bevacizumab Treatment, Alleviated with Conservative Therapy].
Chida S; Matsumoto S; Inoue N; Takenoshita S
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2148-50. PubMed ID: 26805293
[TBL] [Abstract][Full Text] [Related]
16. Clinical predictors of bevacizumab-associated intestinal perforation in non-small cell lung cancer.
Tamiya M; Suzuki H; Shiroyama T; Tanaka A; Morishita N; Okamoto N; Sakai K; Shigeoka H; Kawahara K; Hirashima T
Invest New Drugs; 2018 Aug; 36(4):696-701. PubMed ID: 29536229
[TBL] [Abstract][Full Text] [Related]
17. [A Case of Diverticular Perforation of Sigmoid Colostomy during FOLFIRI plus BevacizumabTreatment].
Watanabe M; Sumi T; Udou R; Enomoto M; Matsudo T; Tachibana S; Mimuro A; Katsumata K; Tsuchida A
Gan To Kagaku Ryoho; 2019 Jan; 46(1):148-150. PubMed ID: 30765670
[TBL] [Abstract][Full Text] [Related]
18. Cost effectiveness of first-line pemetrexed plus platinum compared with other regimens in the treatment of patients with nonsquamous non-small cell lung cancer in the US outpatient setting.
Shah M; Winfree KB; Peterson P; Gruschkus SK; Eaddy M; Green MR
Lung Cancer; 2013 Oct; 82(1):121-7. PubMed ID: 23973203
[TBL] [Abstract][Full Text] [Related]
19. [A Case of Jejunal Perforation by Ramucirumab Just below the Treitz Ligament Treated with Primary Suture].
Kusafuka H; Hata T; Kawai K; Kitahara T; Hiraki M; Shinke G; Katsuyama S; Katsura Y; Omura Y; Masuzawa T; Takeno A; Takeda Y; Murata K
Gan To Kagaku Ryoho; 2021 Dec; 48(13):1932-1934. PubMed ID: 35045451
[TBL] [Abstract][Full Text] [Related]
20. Carboplatin plus Weekly Paclitaxel with Bevacizumab for First-line Treatment of Non-small Cell Lung Cancer.
Kubota T; Okano Y; Sakai M; Takaoka M; Tsukuda T; Anabuki K; Kawase S; Miyamoto S; Ohnishi H; Hatakeyama N; Machida H; Urata T; Yamamoto A; Ogushi F; Yokoyama A
Anticancer Res; 2016 Jan; 36(1):307-12. PubMed ID: 26722058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
